.png)
Accelerating Drug Development for Leading Pharma Firms
Deciphex’s Patholytix platform is transforming drug development for 9 out of the top 10 pharmaceutical companies, enabling them to test hundreds of drug compounds faster and more thoroughly. By providing end-to-end digital studies workflows that are fully GLP-compliant, Patholytix ensures faster regulatory approvals and more accurate assessments, driving critical innovations to market sooner.
Comprehensive Digital Studies Workflows
Patholytix offers a fully integrated, digital-first workflow for pharmaceutical companies and their CRO partners, allowing them to streamline the entire non-clinical testing process. By automating study management and data analysis, the platform removes the bottlenecks of traditional methods, enabling faster decision-making and improving overall drug safety evaluations.
GLP Compliance and Accuracy
Ensuring Good Laboratory Practice (GLP) compliance is key to accelerating drug development, and Patholytix does this by adhering to stringent regulatory standards. In addition, we provide sophisticated computer system validation support, ensuring all processes are robust, compliant, and ready for inspection. This enables pharmaceutical companies to run studies more efficiently, reducing the time and resources spent on regulatory submissions while maintaining high accuracy in safety assessments.
Speeding Up Compound Testing
With Patholytix, hundreds of drug compounds can be tested simultaneously, allowing companies to identify promising candidates faster. By automating routine tasks and integrating AI-powered analysis, the platform boosts throughput without sacrificing data integrity, ensuring that drugs are evaluated quickly and comprehensively.
AI-Driven Decision Support
Patholytix’s use of AI-driven decision support accelerates drug safety assessments by providing real-time insights and automated quality control. This ensures that preclinical safety studies are completed in record time, providing pathologists with only the highest quality slides for assessment. As a result, the efficiency of drug discovery and development pipelines is improved, helping pharmaceutical companies bring life-saving treatments to market faster.
Resources
Foresight: Enhancing Toxicologic Pathology with AI Decision Support - Through Pathologists Insights
Novartis/Deciphex Collaboration
